Osaic Holdings
AUTL

Osaic Holdings’s Autolus Therapeutics AUTL Stock Holding History

Osaic Holdings’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.4K Buy
27,724
+3,150
+13% +$4.94K ﹤0.01% 5568
2026
Q1 		$33.9K Buy
24,574
+4,500
+22% +$6.84K ﹤0.01% 5499
2025
Q4 		$39.9K Buy
20,074
+500
+3% +$768 ﹤0.01% 5391
2025
Q3 		$29.4K Hold
19,574
– – ﹤0.01% 5667
2025
Q2 		$44.6K Sell
19,574
-2,150
-10% -$3.56K ﹤0.01% 5138
2025
Q1 		$33.7K Hold
21,724
– – ﹤0.01% 4992
2024
Q4 		$51.1K Buy
21,724
+1,149
+6% +$3.88K ﹤0.01% 4687
2024
Q3 		$74.7K Hold
20,575
– – ﹤0.01% 4432
2024
Q2 		$71.6K Buy
20,575
+100
+0.5% +$432 ﹤0.01% 4395
2024
Q1 		$131K Sell
20,475
-1,363
-6% -$8.5K ﹤0.01% 4042
2023
Q4 		$141K Buy
21,838
+3,563
+19% +$13.6K ﹤0.01% 4192
2023
Q3 		$42.6K Buy
18,275
+1,025
+6% +$2.92K ﹤0.01% 5097
2023
Q2 		$41.1K Buy
17,250
+325
+2% +$771 ﹤0.01% 5066
2023
Q1 		$31.1K Hold
16,925
– – ﹤0.01% 5293
2022
Q4 		$32.2K Buy
16,925
+16,425
+3,285% +$41.5K ﹤0.01% 5240
2022
Q3 		$1K Hold
500
– – ﹤0.01% 6935
2022
Q2 		$1K Hold
500
– – ﹤0.01% 7031
2022
Q1 		$2K Buy
500
+450
+900% +$1.89K ﹤0.01% 6846
2021
Q4 		$0 Sell
50
-50
-50% -$300 ﹤0.01% 7369
2021
Q3 		$1K Hold
100
– – ﹤0.01% 6970
2021
Q2 		$1K Sell
100
-5,750
-98% -$35.7K ﹤0.01% 6816
2021
Q1 		$34K Buy
5,850
+750
+15% +$5.55K ﹤0.01% 5144
2020
Q4 		$46K Buy
5,100
+100
+2% +$1.07K ﹤0.01% 4602
2020
Q3 		$58K Sell
5,000
-2,500
-33% -$36.3K ﹤0.01% 4191
2020
Q2 		$120K Sell
7,500
-700
-9% -$7.76K ﹤0.01% 3560
2020
Q1 		$46K Buy
+8,200
New +$75.8K ﹤0.01% 4034

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Osaic Holdings's AUTL Position: Q2 2026 in Review

Osaic Holdings increased its Autolus Therapeutics (AUTL) stake by 13% in Q2 2026, buying an estimated $4.94K and bringing the position to 27,724 shares worth $44.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5568.

Osaic Holdings first reported a position in AUTL in Q1 2020 and has held it in 26 quarters since. The position peaked at $141K in Q4 2023. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Osaic Holdings held 27,724 shares of Autolus Therapeutics worth $44.4K as of Q2 2026.
  • Osaic Holdings bought 3,150 Autolus Therapeutics shares in Q2 2026, an estimated $4.94K.
  • Autolus Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5568 holding.
  • Osaic Holdings first reported a position in Autolus Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Autolus Therapeutics position peaked at $141K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.